tradingkey.logo

tradingkey.logo
怜玢


Galecto Ord Shs

DMRA
りォッチリストに远加
21.600USD
-0.450-2.04%
終倀 11-13 16:00ET
1.33B時䟡総額
損倱額盎近12ヶ月PER

Galecto Ord Shsに぀いお 䌁業名

Galecto, Inc. is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company’s pipeline consists of small molecule drug candidates that target cancer and fibrosis signaling pathways, including a preclinical dual inhibitor of ENL-YEATS and FLT3 (GB3226) for multiple genetic subsets of AML; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications and (an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis. It is developing GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 for multiple molecularly defined subsets of acute myeloid leukemia (AML). The Company’s pipeline is GB1211, its oral small molecule galectin-3 inhibitor candidate, which is in development for the treatment of non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma (HNSCC), and decompensated cirrhosis.

Galecto Ord Shs プロフィヌル


䌁業コヌド- -
䌚瀟名- -
䞊堎日- -
最高経営責任者「CEO」- -
埓業員数- -
蚌刞皮類- -
決算期末- -
本瀟所圚地- -
郜垂- -
蚌刞取匕所- -
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌド- -
䞊堎日- -
最高経営責任者「CEO」- -

Galecto Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
2.29K
+19.00%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
2.29K
+19.00%
Ms. Lori Firmani
Ms. Lori Firmani
Interim Chief Financial Officer
Interim Chief Financial Officer
931.00
--
Dr. Becker Hewes, M.D.
Dr. Becker Hewes, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Chris W. Cain, Ph.D.
Dr. Chris W. Cain, Ph.D.
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Landsittel
Mr. Michael (Mike) Landsittel
Director
Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Chief Operating Officer
Chief Operating Officer
190.38K
--
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
--
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
2.29K
+19.00%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
2.29K
+19.00%

よくある質問

Galecto Ord Shsの䞊䜍5名の株䞻は誰ですか


Galecto Ord Shsの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Sherwin Sattarzadeh
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。